Research Interests

Research

Protein Biochemistry, Bioinformatics, Toxicology, Systems Biology, Pharmacogenomics, Biocuration, Proteomics, and Toxicology.

Christine Chim

, Associate Professor

Research

Dr. Chim's research interests include chronic disease state management, pharmacist-run home visits, interprofessional education, preventative health services, social determinants of health, and caring for the underserved. She is a 2017-2020 Fellow of the Clinical Scholars national leadership program supported by the Robert Wood Johnson Foundation.

Nicole M. Maisch

, Associate Clinical Professor

Research

Serve as a faculty mentor to several students conducting Medication-Use Evaluations (MUEs), a method used to identify areas of the medication-use process that may be in need of improvement. This performance improvement process ultimately optimizes patient outcomes and medication safety in our Health-Systems.

Nicole M. Maisch

, Associate Clinical Professor

Research

Serve as a faculty mentor to several students conducting Medication-Use Evaluations (MUEs), a method used to identify areas of the medication-use process that may be in need of improvement. This performance improvement process ultimately optimizes patient outcomes and medication safety in our Health-Systems.

Nitesh K. Kunda

, Assistant Professor

Research

Dr. Kunda’s current research interests include the use of nanotechnology in developing therapeutics against infectious disease and cancer, using targeting moieties for site-specific delivery, amorphous solid dispersions, microneedle-based drug delivery, antimicrobial peptide-based therapeutics, and drug and vaccine formulation for pulmonary delivery. Dr. Kunda’s laboratory specializes in developing dry powder biologics that do not require cold-chain for storage and transport thereby decreasing the cost of biologics-based products significantly.
Dr. Kunda has numerous high-impact peer-reviewed research publications covering a wide variety of topics including formulation, drug delivery, stabilization of vaccines, and health effects due to common environmental toxicants.


 

Ketan D. Patel

, Assistant Professor

Research

The major focus of my research group is to develop a translational drug delivery system/formulations for improving the efficacy and/or patient compliance. Specifically, we are working on; (A) Formulation development and characterization of tumor targeted nanotherapeutics for the treatment of melanoma cancer. Investigating various approaches to enhance penetration of nanocarrier in solid tumor. Exploring overexpressed receptor for metastatic tumor specific delivery of drug loaded nanocarrier (B) Design and Development of pediatric patient tailored formulations (age appropriate dosage from) using 3D printing technology (C) Non-invasive drug delivery system for the treatment of Preterm birth (D) Solubility and bioavailability enhancement of BCS class II and IV drugs using liquisolid technique (E) Opioid abuse deterrent formulation technology

Nitesh K. Kunda

, Assistant Professor

Research

Dr. Kunda’s current research interests include the use of nanotechnology in developing therapeutics against infectious disease and cancer, using targeting moieties for site-specific delivery, amorphous solid dispersions, microneedle-based drug delivery, antimicrobial peptide-based therapeutics, and drug and vaccine formulation for pulmonary delivery. Dr. Kunda’s laboratory specializes in developing dry powder biologics that do not require cold-chain for storage and transport thereby decreasing the cost of biologics-based products significantly.
Dr. Kunda has numerous high-impact peer-reviewed research publications covering a wide variety of topics including formulation, drug delivery, stabilization of vaccines, and health effects due to common environmental toxicants.


 

Research

Protein Biochemistry, Bioinformatics, Toxicology, Systems Biology, Pharmacogenomics, Biocuration, Proteomics, and Toxicology.

Research

Protein Biochemistry, Bioinformatics, Toxicology, Systems Biology, Pharmacogenomics, Biocuration, Proteomics, and Toxicology.

Ketan D. Patel

, Assistant Professor

Research

The major focus of my research group is to develop a translational drug delivery system/formulations for improving the efficacy and/or patient compliance. Specifically, we are working on; (A) Formulation development and characterization of tumor targeted nanotherapeutics for the treatment of melanoma cancer. Investigating various approaches to enhance penetration of nanocarrier in solid tumor. Exploring overexpressed receptor for metastatic tumor specific delivery of drug loaded nanocarrier (B) Design and Development of pediatric patient tailored formulations (age appropriate dosage from) using 3D printing technology (C) Non-invasive drug delivery system for the treatment of Preterm birth (D) Solubility and bioavailability enhancement of BCS class II and IV drugs using liquisolid technique (E) Opioid abuse deterrent formulation technology

Nitesh K. Kunda

, Assistant Professor

Research

Dr. Kunda’s current research interests include the use of nanotechnology in developing therapeutics against infectious disease and cancer, using targeting moieties for site-specific delivery, amorphous solid dispersions, microneedle-based drug delivery, antimicrobial peptide-based therapeutics, and drug and vaccine formulation for pulmonary delivery. Dr. Kunda’s laboratory specializes in developing dry powder biologics that do not require cold-chain for storage and transport thereby decreasing the cost of biologics-based products significantly.
Dr. Kunda has numerous high-impact peer-reviewed research publications covering a wide variety of topics including formulation, drug delivery, stabilization of vaccines, and health effects due to common environmental toxicants.


 

Christine Chim

, Associate Professor

Research

Dr. Chim's research interests include chronic disease state management, pharmacist-run home visits, interprofessional education, preventative health services, social determinants of health, and caring for the underserved. She is a 2017-2020 Fellow of the Clinical Scholars national leadership program supported by the Robert Wood Johnson Foundation.

Nicole M. Maisch

, Associate Clinical Professor

Research

Serve as a faculty mentor to several students conducting Medication-Use Evaluations (MUEs), a method used to identify areas of the medication-use process that may be in need of improvement. This performance improvement process ultimately optimizes patient outcomes and medication safety in our Health-Systems.

Diane Hardej, Ph.D.

, Associate Professor

Research

In vitro and in vivo toxicity and mechanisms of toxicity of metal containing pesticides in the gastrointestinal system as well as neurotoxicity of these agents. In vivo and in vitro neurotoxicity and mechanisms of toxicity of environmental perflournated substances (PFAs)